News






Media
Back
Nikkei Biotech ONLINE – A venture company aiming at practical application of cell medicine for cancer using NK cells –
Our founder Dr. Yoshikazu Yonemitsu (Professor, Kyushu University) and senior advisor Dr. Yui Harada (Assistant Professor, Kyushu University) took an interview with Nikkei Biotech ONLINE
– A venture company aiming at practical application of cell medicine for cancer using NK cells –